517 related articles for article (PubMed ID: 19532026)
1. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.
Antonescu-Turcu AL; Tomic R
Curr Opin Pulm Med; 2009 Mar; 15(2):120-5. PubMed ID: 19532026
[TBL] [Abstract][Full Text] [Related]
2. Chronic obstructive pulmonary disease exacerbations in emergency departments: predictors of outcome.
Roche N; Rabbat A; Zureik M; Huchon G
Curr Opin Pulm Med; 2010 Mar; 16(2):112-7. PubMed ID: 20019614
[TBL] [Abstract][Full Text] [Related]
3. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease.
Hurst JR; Donaldson GC; Perera WR; Wilkinson TM; Bilello JA; Hagan GW; Vessey RS; Wedzicha JA
Am J Respir Crit Care Med; 2006 Oct; 174(8):867-74. PubMed ID: 16799074
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary disease.
Ruiz-González A; Lacasta D; Ibarz M; Martínez-Alonso M; Falguera M; Porcel JM
Respirology; 2008 Nov; 13(7):1028-33. PubMed ID: 18945322
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
[TBL] [Abstract][Full Text] [Related]
6. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD.
Stolz D; Christ-Crain M; Morgenthaler NG; Leuppi J; Miedinger D; Bingisser R; Müller C; Struck J; Müller B; Tamm M
Chest; 2007 Apr; 131(4):1058-67. PubMed ID: 17426210
[TBL] [Abstract][Full Text] [Related]
7. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
8. The value of assessment tests in patients with acute exacerbation of chronic obstructive pulmonary disease.
Zhao YF; Jiang YP; Zhou LF; Wu XL
Am J Med Sci; 2014 May; 347(5):393-9. PubMed ID: 24270077
[TBL] [Abstract][Full Text] [Related]
9. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
[TBL] [Abstract][Full Text] [Related]
10. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia.
Justo D; Lachmi S; Saar N; Joffe E; Atzmony L; Mashav N; Henis O; Sade B; Chundadze T; Steinvil A; Paran Y
Eur J Intern Med; 2009 Sep; 20(5):518-21. PubMed ID: 19712857
[TBL] [Abstract][Full Text] [Related]
12. High sensitive C-reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary disease.
Tofan F; Rahimi-Rad MH; Rasmi Y; Rahimirad S
Pneumologia; 2012; 61(3):160-2. PubMed ID: 23175870
[TBL] [Abstract][Full Text] [Related]
13. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
14. Highly elevated C-reactive protein levels in obese patients with COPD: a fat chance?
Breyer MK; Spruit MA; Celis AP; Rutten EP; Janssen PP; Wouters EF;
Clin Nutr; 2009 Dec; 28(6):642-7. PubMed ID: 19540024
[TBL] [Abstract][Full Text] [Related]
15. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.
Higashimoto Y; Iwata T; Okada M; Satoh H; Fukuda K; Tohda Y
Respir Med; 2009 Aug; 103(8):1231-8. PubMed ID: 19249197
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease (COPD).
Corsonello A; Pedone C; Battaglia S; Paglino G; Bellia V; Incalzi RA
Arch Gerontol Geriatr; 2011; 53(2):190-5. PubMed ID: 21074870
[TBL] [Abstract][Full Text] [Related]
17. Association between serum C- reactive protein levels and other important predictive markers of outcome in COPD.
Shameem M; Bhargava R; Ahmad Z; Saad T; Fatima N; Malik A
Acta Med Iran; 2011; 49(1):18-20. PubMed ID: 21425065
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections.
Müller B; Morgenthaler N; Stolz D; Schuetz P; Müller C; Bingisser R; Bergmann A; Tamm M; Christ-Crain M
Eur J Clin Invest; 2007 Feb; 37(2):145-52. PubMed ID: 17217381
[TBL] [Abstract][Full Text] [Related]
19. Systemic inflammation and mortality in chronic obstructive pulmonary disease.
Sin DD; Man SF
Can J Physiol Pharmacol; 2007 Jan; 85(1):141-7. PubMed ID: 17487253
[TBL] [Abstract][Full Text] [Related]
20. How should we define and classify exacerbations in chronic obstructive pulmonary disease?
Trigueros Carrero JA
Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):33-41. PubMed ID: 23551022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
